News Reduction of share capital Staff April 20, 2022 Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital Iframe sync Post Navigation Previous Clover’s Efficacy Data in Previously-Infected Individuals is Published in Lancet Infectious DiseaseNext Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss More Stories News Restart Life Announces $1,000,000 LIFE Financing Staff July 8, 2025 Healthcare News REPELWRAP(TM) Film Demonstrated Continued Performance Success in Second Real-World Testing and FendX Provides Corporate Update Staff July 8, 2025 Healthcare News First Choice Health Acquires Orderly Health to Redefine Provider Data Management Staff July 8, 2025
